Physician profile
Conrad M Lawrence
NPI 1528383130
$3,067.50
in general payments reported to CMS, 2019-2025
42 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $478 · 2021: $828 · 2022: $553 · 2023: $537 · 2024: $215 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $477.20 | 2020-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $452.95 | 2019-2021 | |
| Abbvie INC. | $248.68 | 2020-2025 | |
| Lilly USA, LLC | $184.40 | 2021-2025 | Zepbound, Mounjaro, Kisunla |
| Abbott Laboratories | $156.55 | 2020-2024 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.45 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $137.92 | 2022 | |
| Amgen INC. | $121.90 | 2019-2023 | Evenity, Prolia |
| Dexcom, INC. | $102.43 | 2022-2025 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $91.51 | 2021 | |
| Glaxosmithkline, LLC. | $86.57 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $81.32 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $53.42 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.34 | 2020-2021 | |
| Gilead Sciences, INC. | $50.28 | 2022-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.